Agile Therapeutics, Inc. Presents Additional Data at American College of Obstetricians and Gynecologist Meeting on Lead Contraceptive Patch Now Entering Phase 3
5/6/2009 10:06:20 AM
More...
|
Agile Therapeutics, Inc. Presents Additional Data at ACOG Meeting on Lead Contraceptive Patch Now Entering Phase 3
5/6/2009 7:17:41 AM
More...
|
NICHD/National Institutes of Health (NIH) to Conduct Clinical Study With Agile Therapeutics, Inc.'s Weekly, Progestin-Only, Contraceptive Patch
3/26/2009 10:35:56 AM
More...
|
Agile Therapeutics, Inc. Abstracts on Lead Product, AG200-15 Accepted by ACOG
12/9/2008 7:26:20 AM
More...
|
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum
12/2/2008 12:29:28 PM
More...
|
Agile Therapeutics, Inc. Announces Issuance of Key Patents for Its SKINFUSION(TM) Technology in Contraception
10/28/2008 10:00:18 AM
More...
|
Agile Therapeutics, Inc. Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch Company to Discuss Phase 3 Plans with FDA
9/3/2008 6:08:18 AM
More...
|
Agile Therapeutics, Inc. Appoints Industry Expert, Al Altomari, as Chairman of Its Board of Directors
8/12/2008 8:46:56 AM
More...
|
Agile Therapeutics, Inc. Appoints Senior Executive Jeffrey Frick as Chief Business Officer
7/8/2008 9:42:54 AM
More...
|
Agile Therapeutics, Inc. Closes $17.6M Series E Venture Financing
12/20/2007 9:57:53 AM
More...
|
|